Page 2 of 7 · 162 questions tagged tirzepatide.
Stated plainly: retatrutide · cagrilintide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
Numbers first: SOUL · dulaglutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence exists and…
For reference: oral semaglutide · semaglutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and…
Details up front: FLOW · orforglipron. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
For reference: PIONEER-4 · survodutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
What I am working with: ESSENCE · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have…
The particulars: liraglutide · cagrilintide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and…
Details up front: SURMOUNT-4 · orforglipron. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
Concretely: ecnoglutide · mazdutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works; the question…
The case in front of me: PIONEER-1 · tirzepatide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at…
Details up front: ATTAIN-1 · retatrutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
For reference: ESSENCE · semaglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like…
For reference: ATTAIN-1 · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like…
Details up front: SELECT · orforglipron. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
I have read the medicinal chemistry paper and the pharmacology paper, which helped and did not finish the job. I am trying to choose between two options that are…
Every comparison I find is either a marketing graphic putting -20.9% next to -14.9% with no caveats, or a methodology piece telling me cross-trial comparison is…
What I am working with: SOUL · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
What I am working with: retatrutide · tirzepatide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
Details up front: PIONEER-1 · retatrutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
The numbers in circulation for reconstituted shelf life are 28 days, 30 days, 56 days and "as long as it looks clear", and I cannot find a source for any of them that…
For reference: oral semaglutide · tirzepatide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and…
The label maximum gets treated as a destination — the "full dose", as though anything below it is partial. But a label maximum is the highest dose a sponsor took…
Conditions: semaglutide · survodutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can…
Numbers first: a GLP-1 receptor agonist · semaglutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…